2023-2029 Global Ropivacaine Mesylate Industry Research & Trends Analysis Report
According to the research report, the global market for Ropivacaine Mesylate should grow from US$ 870 million in 2022 to US$ 1973.3 million by 2029, with a CAGR of 6.4% for the period of 2023-2029.
China Ropivacaine Mesylate market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Ropivacaine Mesylate market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, 2 mg/mL (0.2%) segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Surgical Anesthesia has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Ropivacaine Mesylate include Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP and Zhejiang Xianju Pharmaceutical Co.,Ltd, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup.
This report aims to provide a comprehensive study of the global market for Ropivacaine Mesylate. Key Takeaways and Highlights
(1) Global Ropivacaine Mesylate market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Ropivacaine Mesylate market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Ropivacaine Mesylate market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Ropivacaine Mesylate segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Ropivacaine Mesylate segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Ropivacaine Mesylate, capacity, production and trends.
(7) Ropivacaine Mesylate industry supply chain, upstream, midstream and downstream analysis.
Regional Breakdown: Analyzing Market Segments by Geography
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Segmenting by Type: Comprehensive Coverage and Analysis
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
10 mg/mL (1%)
Application-Based Segmentation: Unlocking Market Opportunities
Surgical Anesthesia
Major Nerve Block
Acute Pain Management
Other
In the Spotlight: A Closer Look at Market Players
Pfizer
Akorn
Anant Pharmaceuticals
SGPharma
Nephron Pharmaceuticals
Sintetica SA
AstraZeneca
Manus Aktteva Biopharma LLP
Zhejiang Xianju Pharmaceutical Co.,Ltd
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Yangzi River Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
1 Market Overview
1.1 Ropivacaine Mesylate Definition
1.2 Global Ropivacaine Mesylate Market Size and Forecast
1.2.1 By Revenue, Global Ropivacaine Mesylate Market Size, 2018-2029
1.2.2 By Sales Volume, Global Ropivacaine Mesylate Market Size, 2018-2029
1.2.3 Global Ropivacaine Mesylate Price Trend, 2018-2029
1.3 China Ropivacaine Mesylate Market Size and Forecast
1.3.1 By Revenue, China Ropivacaine Mesylate Market Size, 2018-2029
1.3.2 By Sales Volume, China Ropivacaine Mesylate Market Size, 2018-2029
1.3.3 China Ropivacaine Mesylate Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Ropivacaine Mesylate Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Ropivacaine Mesylate Share in Global Market, 2018-2029
1.4.3 Ropivacaine Mesylate Market Size: China VS Global, 2018-2029
1.5 Ropivacaine Mesylate Market Dynamics
1.5.1 Ropivacaine Mesylate Market Drivers
1.5.2 Ropivacaine Mesylate Market Restraints
1.5.3 Ropivacaine Mesylate Industry Trends
1.5.4 Ropivacaine Mesylate Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Ropivacaine Mesylate Revenue by Company, 2018-2023
2.2 Global Ropivacaine Mesylate Sales Volume by Company, 2018-2023
2.3 Global Ropivacaine Mesylate Price by Company, 2018-2023
2.4 Global Ropivacaine Mesylate Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Ropivacaine Mesylate Concentration Ratio
2.6 Global Ropivacaine Mesylate Mergers & Acquisitions, Expansion Plans
2.7 Global Ropivacaine Mesylate Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Ropivacaine Mesylate Revenue by Company, 2018-2023
3.2 China Ropivacaine Mesylate Sales Volume by Company, 2018-2023
3.3 China Ropivacaine Mesylate Ropivacaine Mesylate Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Ropivacaine Mesylate Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Ropivacaine Mesylate Domestic VS Export
3.6 China Market, Ropivacaine Mesylate Import & Export
3.6.1 China Market, Ropivacaine Mesylate Import & Export, 2018-2029
3.6.2 China Ropivacaine Mesylate Import & Export Trends
3.6.3 Main Sources of China Ropivacaine Mesylate Import
3.6.4 Export Destination of China Ropivacaine Mesylate
4 Ropivacaine Mesylate Production by Region
4.1 Global Ropivacaine Mesylate Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Ropivacaine Mesylate Manufacturers
4.3 Global Major Manufacturers, Ropivacaine Mesylate Capacity Expansion and Future Plans
4.4 Global Ropivacaine Mesylate Capacity by Region
4.5 Global Ropivacaine Mesylate Production by Region
4.5.1 Global Ropivacaine Mesylate Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Ropivacaine Mesylate Production by Region, 2018-2023
4.5.3 Global Ropivacaine Mesylate Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Ropivacaine Mesylate Industry Chain
5.2 Ropivacaine Mesylate Upstream Analysis
5.2.1 Ropivacaine Mesylate Core Raw Materials
5.2.2 Main Manufacturers of Ropivacaine Mesylate Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Ropivacaine Mesylate Production Mode
5.6 Ropivacaine Mesylate Procurement Model
5.7 Ropivacaine Mesylate Industry Sales Model and Sales Channels
5.7.1 Ropivacaine Mesylate Sales Model
5.7.2 Ropivacaine Mesylate Typical Distributors
6 Sights by Type
6.1 Ropivacaine Mesylate Classification
6.1.1 2 mg/mL (0.2%)
6.1.2 5 mg/mL (0.5%)
6.1.3 7.5 mg/mL (0.75%)
6.1.4 10 mg/mL (1%)
6.2 By Type, Global Ropivacaine Mesylate Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Ropivacaine Mesylate Revenue, 2018-2029
6.4 By Type, Global Ropivacaine Mesylate Sales Volume, 2018-2029
6.5 By Type, Global Ropivacaine Mesylate Price, 2018-2029
7 Sights by Application
7.1 Ropivacaine Mesylate Segment by Application
7.1.1 Surgical Anesthesia
7.1.2 Major Nerve Block
7.1.3 Acute Pain Management
7.1.4 Other
7.2 By Application, Global Ropivacaine Mesylate Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Ropivacaine Mesylate Revenue, 2018-2029
7.4 By Application, Global Ropivacaine Mesylate Sales Volume, 2018-2029
7.5 By Application, Global Ropivacaine Mesylate Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Ropivacaine Mesylate Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Ropivacaine Mesylate Revenue, 2018-2029
8.3 By Region, Global Ropivacaine Mesylate Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Ropivacaine Mesylate Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Ropivacaine Mesylate Market Size Market Share
8.5 Europe
8.5.1 Europe Ropivacaine Mesylate Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Ropivacaine Mesylate Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Ropivacaine Mesylate Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Ropivacaine Mesylate Market Size Market Share
8.7 South America
8.7.1 South America Ropivacaine Mesylate Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Ropivacaine Mesylate Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Ropivacaine Mesylate Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Ropivacaine Mesylate Revenue, 2018-2029
9.3 By Country, Global Ropivacaine Mesylate Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Ropivacaine Mesylate Market Size, 2018-2029
9.4.2 By Company, U.S. Ropivacaine Mesylate Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Ropivacaine Mesylate Market Size, 2018-2029
9.5.2 By Company, Europe Ropivacaine Mesylate Sales Volume Market Share, 2022
9.5.3 By Type, Europe Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Ropivacaine Mesylate Market Size, 2018-2029
9.6.2 By Company, China Ropivacaine Mesylate Sales Volume Market Share, 2022
9.6.3 By Type, China Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Ropivacaine Mesylate Market Size, 2018-2029
9.7.2 By Company, Japan Ropivacaine Mesylate Sales Volume Market Share, 2022
9.7.3 By Type, Japan Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Ropivacaine Mesylate Market Size, 2018-2029
9.8.2 By Company, South Korea Ropivacaine Mesylate Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Ropivacaine Mesylate Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Ropivacaine Mesylate Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Ropivacaine Mesylate Market Size, 2018-2029
9.10.2 By Company, India Ropivacaine Mesylate Sales Volume Market Share, 2022
9.10.3 By Type, India Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Ropivacaine Mesylate Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Ropivacaine Mesylate Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Ropivacaine Mesylate Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Ropivacaine Mesylate Models, Specifications and Application
10.1.3 Pfizer Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 Akorn
10.2.1 Akorn Company Information, Head Office, Market Area and Industry Position
10.2.2 Akorn Ropivacaine Mesylate Models, Specifications and Application
10.2.3 Akorn Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Akorn Company Profile and Main Business
10.2.5 Akorn Recent Developments
10.3 Anant Pharmaceuticals
10.3.1 Anant Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.3.2 Anant Pharmaceuticals Ropivacaine Mesylate Models, Specifications and Application
10.3.3 Anant Pharmaceuticals Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Anant Pharmaceuticals Company Profile and Main Business
10.3.5 Anant Pharmaceuticals Recent Developments
10.4 SGPharma
10.4.1 SGPharma Company Information, Head Office, Market Area and Industry Position
10.4.2 SGPharma Ropivacaine Mesylate Models, Specifications and Application
10.4.3 SGPharma Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 SGPharma Company Profile and Main Business
10.4.5 SGPharma Recent Developments
10.5 Nephron Pharmaceuticals
10.5.1 Nephron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.5.2 Nephron Pharmaceuticals Ropivacaine Mesylate Models, Specifications and Application
10.5.3 Nephron Pharmaceuticals Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Nephron Pharmaceuticals Company Profile and Main Business
10.5.5 Nephron Pharmaceuticals Recent Developments
10.6 Sintetica SA
10.6.1 Sintetica SA Company Information, Head Office, Market Area and Industry Position
10.6.2 Sintetica SA Ropivacaine Mesylate Models, Specifications and Application
10.6.3 Sintetica SA Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sintetica SA Company Profile and Main Business
10.6.5 Sintetica SA Recent Developments
10.7 AstraZeneca
10.7.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.7.2 AstraZeneca Ropivacaine Mesylate Models, Specifications and Application
10.7.3 AstraZeneca Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 AstraZeneca Company Profile and Main Business
10.7.5 AstraZeneca Recent Developments
10.8 Manus Aktteva Biopharma LLP
10.8.1 Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area and Industry Position
10.8.2 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Models, Specifications and Application
10.8.3 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Manus Aktteva Biopharma LLP Company Profile and Main Business
10.8.5 Manus Aktteva Biopharma LLP Recent Developments
10.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
10.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
10.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Models, Specifications and Application
10.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Profile and Main Business
10.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
10.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
10.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
10.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Models, Specifications and Application
10.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Profile and Main Business
10.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments
10.11 Yangzi River Pharmaceutical Group
10.11.1 Yangzi River Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
10.11.2 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Models, Specifications and Application
10.11.3 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Yangzi River Pharmaceutical Group Company Profile and Main Business
10.11.5 Yangzi River Pharmaceutical Group Recent Developments
10.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information, Head Office, Market Area and Industry Position
10.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Models, Specifications and Application
10.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Profile and Main Business
10.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
10.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
10.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
10.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Models, Specifications and Application
10.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Profile and Main Business
10.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Ropivacaine Mesylate Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Ropivacaine Mesylate Market Restraints
Table 3. Ropivacaine Mesylate Market Trends
Table 4. Ropivacaine Mesylate Industry Policy
Table 5. Global Ropivacaine Mesylate Revenue by Company, 2018-2023, US$ million
Table 6. Global Ropivacaine Mesylate Revenue Market Share by Company, 2018-2023
Table 7. Global Ropivacaine Mesylate Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Ropivacaine Mesylate Sales Volume Market Share by Company, 2018-2023
Table 9. Global Ropivacaine Mesylate Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Ropivacaine Mesylate Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Ropivacaine Mesylate Mergers & Acquisitions, Expansion Plans
Table 12. Global Ropivacaine Mesylate Manufacturers Product Type
Table 13. China Ropivacaine Mesylate Revenue by Company, 2018-2023, US$ million
Table 14. China Ropivacaine Mesylate Revenue Market Share by Company, 2018-2023
Table 15. China Ropivacaine Mesylate Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Ropivacaine Mesylate Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Ropivacaine Mesylate Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Ropivacaine Mesylate Import & Export Trends
Table 19. Main Sources of China Ropivacaine Mesylate Import
Table 20. Export Destination of China Ropivacaine Mesylate
Table 21. Global Headquarters and Manufacturing Base of Ropivacaine Mesylate Manufacturers
Table 22. Global Major Manufacturers, Ropivacaine Mesylate Capacity Expansion and Future Plans
Table 23. Global Ropivacaine Mesylate Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Ropivacaine Mesylate Production by Region, 2018-2023, (K Units)
Table 25. Global Ropivacaine Mesylate Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Ropivacaine Mesylate Upstream (Raw Materials)
Table 27. Global Ropivacaine Mesylate Typical Customers
Table 28. Ropivacaine Mesylate Typical Distributors
Table 29. By Type, Global Ropivacaine Mesylate Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Ropivacaine Mesylate Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Ropivacaine Mesylate Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Ropivacaine Mesylate Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Ropivacaine Mesylate Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Ropivacaine Mesylate Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Ropivacaine Mesylate Revenue Market Share, 2018-2029
Table 37. By Country, Global Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Ropivacaine Mesylate Sales Volume Market Share, 2018-2029
Table 39. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Ropivacaine Mesylate Models, Specifications and Application
Table 41. Pfizer Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Company Profile and Main Business
Table 43. Pfizer Recent Developments
Table 44. Akorn Company Information, Head Office, Market Area and Industry Position
Table 45. Akorn Ropivacaine Mesylate Models, Specifications and Application
Table 46. Akorn Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Akorn Company Profile and Main Business
Table 48. Akorn Recent Developments
Table 49. Anant Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 50. Anant Pharmaceuticals Ropivacaine Mesylate Models, Specifications and Application
Table 51. Anant Pharmaceuticals Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Anant Pharmaceuticals Company Profile and Main Business
Table 53. Anant Pharmaceuticals Recent Developments
Table 54. SGPharma Company Information, Head Office, Market Area and Industry Position
Table 55. SGPharma Ropivacaine Mesylate Models, Specifications and Application
Table 56. SGPharma Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. SGPharma Company Profile and Main Business
Table 58. SGPharma Recent Developments
Table 59. Nephron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 60. Nephron Pharmaceuticals Ropivacaine Mesylate Models, Specifications and Application
Table 61. Nephron Pharmaceuticals Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Nephron Pharmaceuticals Company Profile and Main Business
Table 63. Nephron Pharmaceuticals Recent Developments
Table 64. Sintetica SA Company Information, Head Office, Market Area and Industry Position
Table 65. Sintetica SA Ropivacaine Mesylate Models, Specifications and Application
Table 66. Sintetica SA Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Sintetica SA Company Profile and Main Business
Table 68. Sintetica SA Recent Developments
Table 69. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 70. AstraZeneca Ropivacaine Mesylate Models, Specifications and Application
Table 71. AstraZeneca Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. AstraZeneca Company Profile and Main Business
Table 73. AstraZeneca Recent Developments
Table 74. Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area and Industry Position
Table 75. Manus Aktteva Biopharma LLP Ropivacaine Mesylate Models, Specifications and Application
Table 76. Manus Aktteva Biopharma LLP Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Manus Aktteva Biopharma LLP Company Profile and Main Business
Table 78. Manus Aktteva Biopharma LLP Recent Developments
Table 79. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
Table 80. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Models, Specifications and Application
Table 81. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Profile and Main Business
Table 83. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
Table 84. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 85. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Models, Specifications and Application
Table 86. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Profile and Main Business
Table 88. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments
Table 89. Yangzi River Pharmaceutical Group Company Information, Head Office, Market Area and Industry Position
Table 90. Yangzi River Pharmaceutical Group Ropivacaine Mesylate Models, Specifications and Application
Table 91. Yangzi River Pharmaceutical Group Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Yangzi River Pharmaceutical Group Company Profile and Main Business
Table 93. Yangzi River Pharmaceutical Group Recent Developments
Table 94. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 95. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Models, Specifications and Application
Table 96. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Profile and Main Business
Table 98. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
Table 99. Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
Table 100. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Models, Specifications and Application
Table 101. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Profile and Main Business
Table 103. Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments
List of Figure
Figure 1. Ropivacaine Mesylate Picture
Figure 2. By Revenue, Global Ropivacaine Mesylate Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Ropivacaine Mesylate Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Ropivacaine Mesylate Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Ropivacaine Mesylate Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Ropivacaine Mesylate Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Ropivacaine Mesylate Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Ropivacaine Mesylate Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Ropivacaine Mesylate Share of Global Market, 2018-2029
Figure 10. Global Ropivacaine Mesylate Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Ropivacaine Mesylate Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Ropivacaine Mesylate Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Ropivacaine Mesylate Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Ropivacaine Mesylate Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Ropivacaine Mesylate Domestic VS Export, 2022
Figure 16. Global Ropivacaine Mesylate Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Ropivacaine Mesylate Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Ropivacaine Mesylate Production Market Share & Forecast by Region, 2018-2029
Figure 19. Ropivacaine Mesylate Industry Chain
Figure 20. Ropivacaine Mesylate Procurement Model
Figure 21. Ropivacaine Mesylate Sales Model
Figure 22. Ropivacaine Mesylate Sales Channels, Direct Sales and Distribution
Figure 23. 2 mg/mL (0.2%)
Figure 24. 5 mg/mL (0.5%)
Figure 25. 7.5 mg/mL (0.75%)
Figure 26. 10 mg/mL (1%)
Figure 27. By Type, Global Ropivacaine Mesylate Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Ropivacaine Mesylate Revenue Market Share, 2018-2029
Figure 29. By Type, Global Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Ropivacaine Mesylate Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Ropivacaine Mesylate Price, 2018-2029, (US$/Unit)
Figure 32. Surgical Anesthesia
Figure 33. Major Nerve Block
Figure 34. Acute Pain Management
Figure 35. Other
Figure 36. By Application, Global Ropivacaine Mesylate Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Ropivacaine Mesylate Revenue Market Share, 2018-2029
Figure 38. By Application, Global Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global Ropivacaine Mesylate Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Ropivacaine Mesylate Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global Ropivacaine Mesylate Revenue Market Share, 2018-2029
Figure 42. By Region, Global Ropivacaine Mesylate Sales Volume Market Share, 2018-2029
Figure 43. North America Ropivacaine Mesylate Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America Ropivacaine Mesylate Revenue Market Share, 2022
Figure 45. Europe Ropivacaine Mesylate Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe Ropivacaine Mesylate Revenue Market Share, 2022
Figure 47. Asia Pacific Ropivacaine Mesylate Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific Ropivacaine Mesylate Revenue Market Share, 2022
Figure 49. South America Ropivacaine Mesylate Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America Ropivacaine Mesylate Revenue Market Share, 2022
Figure 51. Middle East & Africa Ropivacaine Mesylate Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, U.S. Ropivacaine Mesylate Market Share, 2022
Figure 54. By Type, U.S. Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, Europe Ropivacaine Mesylate Market Share, 2022
Figure 58. By Type, Europe Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 60. China Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, China Ropivacaine Mesylate Market Share, 2022
Figure 62. By Type, China Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, Japan Ropivacaine Mesylate Market Share, 2022
Figure 66. By Type, Japan Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, South Korea Ropivacaine Mesylate Market Share, 2022
Figure 70. By Type, South Korea Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, Southeast Asia Ropivacaine Mesylate Market Share, 2022
Figure 74. By Type, Southeast Asia Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 76. India Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, India Ropivacaine Mesylate Market Share, 2022
Figure 78. By Type, India Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Ropivacaine Mesylate Sales Volume, 2018-2029, (K Units)
Figure 81. By Company, Middle East & Asia Ropivacaine Mesylate Market Share, 2022
Figure 82. By Type, Middle East & Asia Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Ropivacaine Mesylate Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|